Showing results (501-510 of 561) with videos related to

Sort By:
Pageof 57
JCO Precision Oncology|January 20, 2022
Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the ProstateWilliam A Hall, Nick Fishbane, Yang Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2022
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA TrialPhuoc T Tran, Kathryn Lowe, Hua-Ling Tsai, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistanceJoshi J Alumkal, Duanchen Sun, Eric Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2019
DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling PathwayVishal Kothari, Jonathan F Goodwin, Shuang G Zhao, et al.
European Urology|May 29, 2020
Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate CancerAmar U Kishan, Tahmineh Romero, Mohammed Alshalalfa, et al.
Journal of the American Medical Informatics Association : JAMIA|September 13, 2016
Assessing electronic health record phenotypes against gold-standard diagnostic criteria for diabetes mellitusSusan E Spratt, Katherine Pereira, Bradi B Granger, et al.
Nature Communications|May 13, 2022
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targetsXintao Qiu, Nadia Boufaied, Tarek Hallal, et al.
Pageof 57